NEURO61

Session information

[held on paper]English Poster Session

[Pe-17] English Poster Session 17
Neuroimmunity (clinical research 3)

Akiko Nagaishi1,2, Sudarshini Ramanathan2,3, Deniz Akdeniz2, Anne-kathrin Kienzler2, Andrew Fower2, Mark Woodhall2, Bo Sun2, Valentina Damato2, Lynn Dustin4, Jacqueline Palace2,5, Nick Willcox2, M Isabel Leite2,5, Mateusz Makuch2, Patrick J Waters2, Sarosh R Irani2,5 (1.Department of Neurology, NHO Nagasaki Kawatana Medical Center, Japan, 2.Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital; University of Oxford, UK, 3.Sydney Medical School, University of Sydney; Kids Neuroscience Centre, Children's Hospital at Westmead, 4.Viral Infection and Immunity Group; Medical Sciences Division, University of Oxford, 5.Department of Neurology, Oxford University Hospitals Trust)

Kimihiko Kaneko1,2, Toshiyuki Takahashi2,3, Douglas Kazutoshi Sato2,4, Yoshiki Takai2, Shuhei Nishiyama2, Tatsuro Misu2, Ichiro Nakashima2,5, Kazuo Fujihara2,6,7, Masashi Aoki2 (1.Department of neurology, NHO Miyagi National Hospital, Japan, 2.Department of Neurology, Tohoku University school of medicine, Japan, 3.Department of Neurology, NHO Yonezawa National Hospital, 4.Department of Neurology, Brain Institute and hospital sao Lucas pontifical catholic University of Rio Grande do sul, porto alegre, Brazil, 5.Department of Neurology, Tohoku Medical and pharmaceutical University, 6.Department of Multiple sclerosis Therapeutics, Fukushima Medical University, 7.Multiple sclerosis and Neuromyelitis Optica center, Tohoku Research Institute for Neuroscience)

Satoru Oji, Satoru Tanaka, Shinya Narukawa, Shoko Izaki, Masaomi Yamamoto, Tetsuo Yamaga, Baku Hashimoto, Kohei Sugimoto, Mayumi Furuya, Atsuo Miyauchi, Keita Ishizuka, Masato Suzuki, Takashi Tajima, Wataru Hara, Norihito Yoshida, Tomohisa Dembo, Hikoaki Fukaura, Kyoichi Nomura (Department of Neurology, Saitama Medical Center, Saitama Medical University, Japan)

Shoko Fukumoto1, Yuri Nakamura1,2, Mitsuru Watanabe1, Noriko Isobe3, Takuya Matsushita1, Ayako Sakoda1, Ryo Yamasaki1, Jun-ichi Kira1 (1.Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan, 2.Department of Neurology, Fukuoka Central Hospital, International University of Health and Welfare, Fukuoka, Japan, 3.Department of Neurological Therapeutics, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan)

Keita Takahashi1, Hideyuki Takeuchi1, Misako Kunii1, Atsuko Katsumoto1, Mikiko Tada1, Hiroshi Doi1, Kohtaro Takei2, Fumiaki Tanaka1 (1.Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Japan, 2.Molecular Medical Bioscience Laboratory, Department of Medical Life Science, Yokohama City University Graduate School of Medical Life Science)

Misako Minote1,4, Wakiro Sato1,2, Tomoko Okamoto3, Ryosuke Takahashi4, Takashi Yamamura1,2 (1.Department of Immunology, National Center of Neurology and Psychiatry, Japan, 2.Multiple Sclerosis Center, National Center Hospital, National Center of Neurology and Psychiatry (NCNP), Japan, 3.Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry (NCNP), Japan, 4.Department of Neurology, Kyoto University Graduate School of Medicine, Japan)